NEW YORK (GenomeWeb News) – Rosetta Genomics today said it has received full payment from Sanra Laboratories to settle a dispute over Sanra's purchase of Parkway Clinical Laboratories from Rosetta in 2009.

Sanra paid Rosetta $625,000 as part of the settlement announced last month between the firms. Under the terms of the agreement, Sanra agreed to pay Rosetta $625,000 on top of all other payments it has paid Rosetta "for total consideration of all their obligations." Sanra previously paid Rosetta $10,000 up front.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.